Microsclerotherapy as a modality of treatment in superficial venous malformations

Authors

  • Farid Ahmad Khan Plastic surgery department, King Edward Medical College/Mayo Hospital, Lahore
  • Khalil Al Nakib Laser Suite, Department of Plastic Surgery, St. John’s Hospital, Livingston, U.K
  • Abdul Rehman Awf Quaba Laser Suite, Department of Plastic Surgery, St. John’s Hospital, Livingston, U.K

DOI:

https://doi.org/10.66344/jpad.v13i2.735

Keywords:

Microsclerotherapy, venous malformation

Abstract

Venous malformation is a difficult clinical problem with a wide spectrum. There is a continuum of localized venous malformations from blue telangiectatic capillaries through spongy blebs, through cavernous lesions to diffuse venous ectasias. Apart from cosmetic concern majority of localized superficial venous malformations are asymptomatic and managed by explanation and reassurance. With the advent of laser therapy patients with this distinct group of superficial flat venous malformations were referred to our laser suite. Response to laser therapy was poor because of large diameter of the abnormal vessels. Microsclerotherapy, an established method of treatment of lower limb telangiectasias, was tried on twenty five patients with localized superficial malformations. The outcome was satisfactory indicating that microsclerotherapy can be used safely as an effective modality of treatment for superficial malformations.

References

Berenguer B, Burrows PE, Zurakowski D, Mulliken JB. Sclerotherapy of craniofacial venous malformations: complications and results. Plast Reconstr Surg 1999; 104: 1-9.

Georgantopoulou AA, Al-Nakib K, Quaba AA.Treatment of arborising telangiectasia with pulsed tunable dye laser. Br J Plast Surg 1999; 51: 614-20.

Quaba AA. Telangiectasia. Is treatment worthwhile and who should pay? In: Ruckley V, ed. Epidemiology, management and delivery of care for venous disease. 1st edn. London: Springer-Verlag; 1999.

Imhoff E, Stemmer R. Classification and mechanism of sclerosing agents. Soc Franc Phlebol 1969; 22: 143-5.

Sadik NS. Sclerotherapy of varicose and telangiectatic leg veins: Minimal sclerosing agent concentration of hypertonic saline and its relationship to vessel diameter. J Dermatol Surg Oncol 1991; 17: 65-9.

Goldman MP, Kaplan RP, Duffy DM. Postsclerotherapy hyperpigmentation: A histologic evaluation. J Dermatol Surg Oncol; 13: 547-51.

Carlin MC, Ratz JL. Treatment of telangiectasia: comparison of sclerosing agents. J Dermatol Surg Oncol 1991; 17: 75-9.

Goldman MP, Fitzpatrick RE, eds. Sclerotherapy as treatment of vericose and telengiactatic leg vein., 1st edn. New York: Mosby; 1995.

Downloads

Published

03.01.2017

Issue

Section

Original Articles

How to Cite

1.
Microsclerotherapy as a modality of treatment in superficial venous malformations. J Pak Assoc Dermatol [Internet]. 2017 Jan. 3 [cited 2026 Aug. 3];13(2):72-5. Available from: https://www.jpad.com.pk/index.php/jpad/article/view/735